Peninsula biopharma wins 1st FDA approval for drug targeting type of brain cancer in kids
The company was supposed to hear back from the FDA next week, but the agency made a rare ahead-of-schedule decision.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ron Leuty Source Type: news
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Children | Health Management | Neurology | Pharmaceuticals